Islet cell xenotransplantation: A serious look toward the clinic

Kannan P. Samy, Benjamin M. Martin, Nicole A. Turgeon, Allan D. Kirk*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

41 Scopus citations


Type I diabetes remains a significant clinical problem in need of a reliable, generally applicable solution. Both whole organ pancreas and islet allotransplantation have been shown to grant patients insulin independence, but organ availability has restricted these procedures to an exceptionally small subset of the diabetic population. Porcine islet xenotransplantation has been pursued as a potential means of overcoming the limits of allotransplantation, and several preclinical studies have achieved near-physiologic function and year-long survival in clinically relevant pig-to-primate model systems. These proof-of-concept studies have suggested that xenogeneic islets may be poised for use in clinical trials. In this review, we examine recent progress in islet xenotransplantation, with a critical eye toward the gaps between the current state of the art and the state required for appropriate clinical investigation.

Original languageEnglish
Pages (from-to)221-229
Number of pages9
Issue number3
StatePublished - 2014
Externally publishedYes


  • artificial pancreas
  • clinical trial
  • ethics
  • genetically engineered animals
  • immunosuppression
  • islet transplantation
  • xenotransplantation


Dive into the research topics of 'Islet cell xenotransplantation: A serious look toward the clinic'. Together they form a unique fingerprint.

Cite this